Simple Reversed-Phase High Performance Liquid Chromatographic Estimation of the Antiretroviral Agent Efavirenz from Human Plasma
Journal Title: Journal of Pharmaceutical Research International - Year 2014, Vol 4, Issue 1
Abstract
Aims: Sequel to the resurgence of TB co-infection in HIV/AIDS patients in sub-Saharan Africa, efavirenz has become an important component of the highly active antiretroviral treatment (HAART). The objective of this study therefore is to provide a simple reversed-phase high performance liquid chromatographic (HPLC) method for the determination of efavirenz in human plasma. Study Design: Method development and experimental study. Place and Duration of Study: School of Pharmacy, University of Nairobi, Nairobi, Kenya, between October 2009 and September 2010. Methodology: A 500µl drug-free plasma sample was each placed in six different centrifuge tubes (2ml) and varying aliquots of the stock solution (100μg/ml) of efavirenz were spiked and vortexed for 60sec to give concentrations of 0.5, 1.0, 2.0, 4.0, 8.0 and 16µg/ml for calibration standards and 2.0, 4.0, 8.0 and 16.0µg/ml for quality control samples. The off-column sample pretreatment was carried out by protein precipitation using ice-cold acetonitrile. The samples were chromatographed in a phenomenex (C18) 5µm particle size column with 250x4.6mm I.D and UV detection at 254nm using a mobile phase, which was made up of a mixture of solutions A and B. Both consisted of acetonitrile, 25mM ammonium acetate buffer and glacial acetic acid in proportions of 90:10:0.1 and 10:90:0.1(v/v), respectively. The analytical technique was validated for precision, accuracy and analyte recovery. Results: The calibration plot for efavirenz was found to be linear over the concentration range of 0.5 to 16.0µg/ml with the regression line equation obtained as y=26842x–409.4 and the regression coefficient (R2=0.999), which allows for accurate reading of the concentrations of the test samples. The RSD (%) in intraday and interday assays ranged from 0.44 to 0.78%. Accuracy ranged from 92 to 110% and the recovery was >97%. Conclusion: This new HPLC method is simple, reproducible and cost-effective and can be used for therapeutic drug monitoring of efavirenz in HIV/AIDS patients on HAART as demonstrated in this study.
Authors and Affiliations
Benjamin U. Ebeshi, Oluseye O. Bolaji, Margaret Oluka, Vaikosen N. Edebi, Julius O. Soyinka, Anastasia Guantai
Keywords
Related Articles
- EP ID EP344749
- DOI 10.9734/BJPR/2014/4123
- Views 70
- Downloads 0
Assessment of Quality of “Dhanyamla”: A Fermented Cereal Used in Ayurveda
Aim: Dhanyamla is a medicinal preparation having great therapeutic values which is described under the Sandhana Kalpana in Ayurveda texts. In the present study, an attempt was made to assess the quality of Dhanyamla by u...
Molecular Typing and Antimicrobial Susceptibility of Acinetobacter baumannii Isolates in Kermanshah City with Pulse Field Gel Electrophoresis (PFGE)
Background and Objective: Acinetobacter baumannii (A. baumannii) in the last decade has been identified as one of the opportunistic pathogens and an important cause of nosocomial infections. Molecular typing plays an imp...
Uterine Relaxation Potential of Ethanol Leaf Extract of Moringa oleifera Lam. VIA the Muscarinic Receptor Pathway
Aim: The effect of Ethanol Leaf Extract of Moringa oleifera (ELMO) on uterine smooth muscles of non- pregnant female rats was studied in vitro with a view to finding out the mechanism(s) for observed effects. Experientia...
Acetyl and Butyrylcholinesterase Inhibiting Constituent from Morinda lucida Benth (Rubiaceae)
Aims: This study identified the cholinesterase inhibitory principle in Morinda lucida, one of the plants used in Nigerian ethnomedicine as memory enhancer. Study Design: In vitro anti cholinesterase assay and spectroscop...
Exploration of the Angiogenic Potential of Honey
Aims: The present study was conducted to confirm the angiogenic potential of honey using Chick Chorioallantoic Membrane (CAM), an in ovo model and to study its effect on Vascular Endothelial Growth Factor (VEGF) expressi...